Novel motif:87: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:59, 9 September 2013
name: | motif87_RCGCACWS |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0038007 | netrin-activated signaling pathway | 1.600587e-8 |
GO:0002074 | extraocular skeletal muscle development | 1.714743e-8 |
GO:0021903 | rostrocaudal neural tube patterning | 8.216173e-8 |
GO:0050746 | regulation of lipoprotein metabolic process | 8.860561e-8 |
GO:0019101 | female somatic sex determination | 1.089841e-7 |
GO:0042703 | menstruation | 1.089841e-7 |
GO:0021535 | cell migration in hindbrain | 1.540812e-7 |
GO:0021536 | diencephalon development | 2.169174e-7 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.486469e-7 |
GO:0014028 | notochord formation | 2.771629e-7 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 3.239800e-7 |
GO:0008635 | activation of caspase activity by cytochrome c | 4.844188e-7 |
GO:0070192 | chromosome organization involved in meiosis | 5.254200e-7 |
GO:0043301 | negative regulation of leukocyte degranulation | 6.274260e-7 |
GO:0035094 | response to nicotine | 7.542050e-7 |
GO:0010765 | positive regulation of sodium ion transport | 9.449853e-7 |
GO:0033057 | multicellular organismal reproductive behavior | 1.015634e-6 |
GO:0043305 | negative regulation of mast cell degranulation | 1.809796e-6 |
GO:0014806 | smooth muscle hyperplasia | 2.282681e-6 |
GO:0007288 | sperm axoneme assembly | 2.670066e-6 |
GO:0050703 | interleukin-1 alpha secretion | 2.855928e-6 |
GO:0000089 | mitotic metaphase | 3.229700e-6 |
GO:0009650 | UV protection | 3.668877e-6 |
GO:0071258 | cellular response to gravity | 3.848089e-6 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 3.848089e-6 |
GO:0061044 | negative regulation of vascular wound healing | 3.848089e-6 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 3.848089e-6 |
GO:0007128 | meiotic prophase I | 3.918824e-6 |
GO:0033590 | response to cobalamin | 4.268985e-6 |
GO:0006117 | acetaldehyde metabolic process | 4.268985e-6 |
GO:0071460 | cellular response to cell-matrix adhesion | 4.290701e-6 |
GO:0007286 | spermatid development | 6.865742e-6 |
GO:0006473 | protein acetylation | 8.437376e-6 |
GO:0090102 | cochlea development | 8.699624e-6 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 8.733199e-6 |
GO:0006475 | internal protein amino acid acetylation | 9.745147e-6 |
GO:0006383 | transcription from RNA polymerase III promoter | 9.928031e-6 |
GO:0003105 | negative regulation of glomerular filtration | 1.091634e-5 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 1.115192e-5 |
GO:0006386 | termination of RNA polymerase III transcription | 1.137034e-5 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.137034e-5 |
GO:0055075 | potassium ion homeostasis | 1.186021e-5 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 1.251743e-5 |
GO:0048515 | spermatid differentiation | 1.308495e-5 |
GO:0022601 | menstrual cycle phase | 1.344543e-5 |
GO:0018205 | peptidyl-lysine modification | 1.377994e-5 |
GO:0010224 | response to UV-B | 1.560490e-5 |
GO:0021675 | nerve development | 1.765357e-5 |
GO:0007638 | mechanosensory behavior | 1.873261e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 2.021706e-5 |
GO:0060033 | anatomical structure regression | 2.046639e-5 |
GO:0021603 | cranial nerve formation | 2.470948e-5 |
GO:0033683 | nucleotide-excision repair, DNA incision | 2.470948e-5 |
GO:0007129 | synapsis | 2.481418e-5 |
GO:0021877 | forebrain neuron fate commitment | 2.718575e-5 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.967479e-5 |
GO:0045760 | positive regulation of action potential | 2.968095e-5 |
GO:0021932 | hindbrain radial glia guided cell migration | 3.143746e-5 |
GO:0021879 | forebrain neuron differentiation | 3.292618e-5 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 3.429231e-5 |
GO:0009296 | flagellum assembly | 3.659001e-5 |
GO:0043491 | protein kinase B signaling cascade | 3.677974e-5 |
GO:0021559 | trigeminal nerve development | 3.728672e-5 |
GO:0014040 | positive regulation of Schwann cell differentiation | 3.904165e-5 |
GO:0043543 | protein acylation | 3.958221e-5 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 4.070992e-5 |
GO:0002200 | somatic diversification of immune receptors | 4.198139e-5 |
GO:0010721 | negative regulation of cell development | 4.373903e-5 |
GO:0007130 | synaptonemal complex assembly | 4.747131e-5 |
GO:0046108 | uridine metabolic process | 5.224923e-5 |
GO:0018394 | peptidyl-lysine acetylation | 5.267081e-5 |
GO:0006308 | DNA catabolic process | 5.295723e-5 |
GO:0033233 | regulation of protein sumoylation | 5.418573e-5 |
GO:0007616 | long-term memory | 5.725978e-5 |
GO:0060591 | chondroblast differentiation | 5.733985e-5 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 5.779498e-5 |
GO:0060035 | notochord cell development | 5.849022e-5 |
GO:0018393 | internal peptidyl-lysine acetylation | 5.882567e-5 |
GO:0045116 | protein neddylation | 5.939809e-5 |
GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 6.516652e-5 |
GO:0033235 | positive regulation of protein sumoylation | 6.523697e-5 |
GO:0042369 | vitamin D catabolic process | 6.975665e-5 |
GO:0051323 | metaphase | 7.161307e-5 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 7.197392e-5 |
GO:0051324 | prophase | 7.215705e-5 |
GO:0060014 | granulosa cell differentiation | 7.275751e-5 |
GO:0021983 | pituitary gland development | 7.660335e-5 |
GO:0021545 | cranial nerve development | 7.780358e-5 |
GO:0006108 | malate metabolic process | 7.788523e-5 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 7.849926e-5 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 8.331473e-5 |
GO:0031223 | auditory behavior | 8.929221e-5 |
GO:0060596 | mammary placode formation | 9.458959e-5 |
GO:0019087 | transformation of host cell by virus | 1.033583e-4 |
GO:0042069 | regulation of catecholamine metabolic process | 1.067024e-4 |
GO:0006821 | chloride transport | 1.070438e-4 |
GO:0072148 | epithelial cell fate commitment | 1.094808e-4 |
GO:0045792 | negative regulation of cell size | 1.169424e-4 |
GO:0045471 | response to ethanol | 1.169835e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.170853e-4 |
GO:0051260 | protein homooligomerization | 1.289006e-4 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 1.326817e-4 |
GO:0033151 | V(D)J recombination | 1.375170e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 1.378737e-4 |
GO:0031017 | exocrine pancreas development | 1.383058e-4 |
GO:0008654 | phospholipid biosynthetic process | 1.432280e-4 |
GO:0007020 | microtubule nucleation | 1.449871e-4 |
GO:0014707 | branchiomeric skeletal muscle development | 1.525622e-4 |
GO:0021707 | cerebellar granule cell differentiation | 1.530815e-4 |
GO:0030852 | regulation of granulocyte differentiation | 1.556240e-4 |
GO:0060026 | convergent extension | 1.644819e-4 |
GO:0072592 | oxygen metabolic process | 1.665250e-4 |
GO:0021794 | thalamus development | 1.698279e-4 |
GO:0001661 | conditioned taste aversion | 1.702355e-4 |
GO:0021872 | forebrain generation of neurons | 1.742946e-4 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.767602e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 1.767602e-4 |
GO:0032223 | negative regulation of synaptic transmission, cholinergic | 1.767602e-4 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.767602e-4 |
GO:0007420 | brain development | 1.783472e-4 |
GO:0014037 | Schwann cell differentiation | 1.816135e-4 |
GO:0032411 | positive regulation of transporter activity | 1.863450e-4 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.907748e-4 |
GO:0035261 | external genitalia morphogenesis | 2.001161e-4 |
GO:0032741 | positive regulation of interleukin-18 production | 2.016428e-4 |
GO:0009956 | radial pattern formation | 2.016428e-4 |
GO:0032464 | positive regulation of protein homooligomerization | 2.080032e-4 |
GO:0018208 | peptidyl-proline modification | 2.219834e-4 |
GO:0050768 | negative regulation of neurogenesis | 2.374818e-4 |
GO:0006788 | heme oxidation | 2.409851e-4 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 2.415707e-4 |
GO:0016573 | histone acetylation | 2.481035e-4 |
GO:0048562 | embryonic organ morphogenesis | 2.537679e-4 |
GO:0021943 | formation of radial glial scaffolds | 2.582428e-4 |
GO:0031104 | dendrite regeneration | 2.668620e-4 |
GO:0010939 | regulation of necrotic cell death | 2.774449e-4 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 2.787602e-4 |
GO:0003406 | retinal pigment epithelium development | 2.905460e-4 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 2.948121e-4 |
GO:0030574 | collagen catabolic process | 2.978369e-4 |
GO:0042552 | myelination | 3.044299e-4 |
GO:0045007 | depurination | 3.090811e-4 |
GO:0022011 | myelination in peripheral nervous system | 3.228761e-4 |
GO:0014014 | negative regulation of gliogenesis | 3.399148e-4 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 3.459905e-4 |
GO:0030262 | apoptotic nuclear change | 3.509831e-4 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 3.677841e-4 |
GO:0030917 | midbrain-hindbrain boundary development | 3.803750e-4 |
GO:0032007 | negative regulation of TOR signaling cascade | 3.807074e-4 |
GO:0021557 | oculomotor nerve development | 3.887627e-4 |
GO:0040018 | positive regulation of multicellular organism growth | 3.953987e-4 |
GO:0014044 | Schwann cell development | 4.005030e-4 |
GO:0050905 | neuromuscular process | 4.052115e-4 |
GO:0014038 | regulation of Schwann cell differentiation | 4.212240e-4 |
GO:0040040 | thermosensory behavior | 4.250474e-4 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 4.411721e-4 |
GO:0034470 | ncRNA processing | 4.431200e-4 |
GO:0001830 | trophectodermal cell fate commitment | 4.448302e-4 |
GO:0044335 | canonical Wnt receptor signaling pathway involved in neural crest cell differentiation | 4.448302e-4 |
GO:0030902 | hindbrain development | 4.457704e-4 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.491230e-4 |
GO:0042053 | regulation of dopamine metabolic process | 4.720637e-4 |
GO:0021895 | cerebral cortex neuron differentiation | 4.776471e-4 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 4.816598e-4 |
GO:0032774 | RNA biosynthetic process | 4.871460e-4 |
GO:0006351 | transcription, DNA-dependent | 4.871524e-4 |
GO:0006682 | galactosylceramide biosynthetic process | 5.029955e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 5.349784e-4 |
GO:0018993 | somatic sex determination | 5.471648e-4 |
GO:0021511 | spinal cord patterning | 5.606198e-4 |
GO:0032971 | regulation of muscle filament sliding | 5.618887e-4 |
GO:0043966 | histone H3 acetylation | 5.638967e-4 |
GO:0035136 | forelimb morphogenesis | 5.638967e-4 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 5.754298e-4 |
GO:0042711 | maternal behavior | 5.777058e-4 |
GO:0033566 | gamma-tubulin complex localization | 5.865470e-4 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 5.865470e-4 |
GO:0006384 | transcription initiation from RNA polymerase III promoter | 5.865470e-4 |
GO:0018872 | arsonoacetate metabolic process | 6.074206e-4 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 6.074206e-4 |
GO:0001514 | selenocysteine incorporation | 6.108896e-4 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 6.265050e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 6.300502e-4 |
GO:0003310 | pancreatic A cell differentiation | 6.306260e-4 |
GO:0045022 | early endosome to late endosome transport | 6.486230e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.598921e-4 |
GO:0003016 | respiratory system process | 6.755597e-4 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 6.856611e-4 |
GO:0021854 | hypothalamus development | 6.856611e-4 |
GO:0043687 | post-translational protein modification | 6.894201e-4 |
GO:0048570 | notochord morphogenesis | 7.080642e-4 |
GO:0021861 | forebrain radial glial cell differentiation | 7.083343e-4 |
GO:0008366 | axon ensheathment | 7.371380e-4 |
GO:0060716 | labyrinthine layer blood vessel development | 7.398247e-4 |
GO:0046113 | nucleobase catabolic process | 7.586989e-4 |
GO:0042167 | heme catabolic process | 7.670979e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 7.783123e-4 |
GO:0071726 | cellular response to diacyl bacterial lipopeptide | 7.783123e-4 |
GO:0042496 | detection of diacyl bacterial lipopeptide | 7.783123e-4 |
GO:0070193 | synaptonemal complex organization | 7.885141e-4 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 8.067858e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 8.207800e-4 |
GO:0043313 | regulation of neutrophil degranulation | 8.312430e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 8.576311e-4 |
GO:0018193 | peptidyl-amino acid modification | 8.593292e-4 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 8.680573e-4 |
GO:0015824 | proline transport | 9.198563e-4 |
GO:0032205 | negative regulation of telomere maintenance | 9.371564e-4 |
GO:0006927 | transformed cell apoptosis | 9.592865e-4 |
GO:0043585 | nose morphogenesis | 9.592865e-4 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 1.043678e-3 |
GO:0090370 | negative regulation of cholesterol efflux | 1.051543e-3 |
GO:0010980 | positive regulation of vitamin D 24-hydroxylase activity | 1.051543e-3 |
GO:0071169 | establishment of protein localization to chromatin | 1.054024e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 1.061484e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 1.061484e-3 |
GO:0071281 | cellular response to iron ion | 1.064484e-3 |
GO:0033687 | osteoblast proliferation | 1.174346e-3 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1.174346e-3 |
GO:0019637 | organophosphate metabolic process | 1.180053e-3 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 1.194584e-3 |
GO:0000966 | RNA 5'-end processing | 1.203405e-3 |
GO:0032781 | positive regulation of ATPase activity | 1.208564e-3 |
GO:0021506 | anterior neuropore closure | 1.234195e-3 |
GO:0014916 | regulation of lung blood pressure | 1.234195e-3 |
GO:0032863 | activation of Rac GTPase activity | 1.236698e-3 |
GO:0035356 | cellular triglyceride homeostasis | 1.262630e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 1.284144e-3 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.291106e-3 |
GO:0006235 | dTTP biosynthetic process | 1.329297e-3 |
GO:0051289 | protein homotetramerization | 1.371794e-3 |
GO:0000019 | regulation of mitotic recombination | 1.389968e-3 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 1.394599e-3 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 1.397867e-3 |
GO:0017121 | phospholipid scrambling | 1.415008e-3 |
GO:0030225 | macrophage differentiation | 1.416378e-3 |
GO:0045820 | negative regulation of glycolysis | 1.434627e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.442436e-3 |
GO:0032661 | regulation of interleukin-18 production | 1.457744e-3 |
GO:0060021 | palate development | 1.459454e-3 |
GO:0048625 | myoblast cell fate commitment | 1.459912e-3 |
GO:0045444 | fat cell differentiation | 1.462597e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 1.470390e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 1.470390e-3 |
GO:0048841 | regulation of axon extension involved in axon guidance | 1.482556e-3 |
GO:0030237 | female sex determination | 1.484362e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 1.494801e-3 |
GO:0001300 | chronological cell aging | 1.503554e-3 |
GO:0050771 | negative regulation of axonogenesis | 1.524167e-3 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1.567735e-3 |
GO:0046655 | folic acid metabolic process | 1.568803e-3 |
GO:0071727 | cellular response to triacyl bacterial lipopeptide | 1.570685e-3 |
GO:0042495 | detection of triacyl bacterial lipopeptide | 1.570685e-3 |
GO:0015840 | urea transport | 1.570685e-3 |
GO:0060073 | micturition | 1.734413e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 1.734413e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.734413e-3 |
GO:0050690 | regulation of defense response to virus by virus | 1.745302e-3 |
GO:0001508 | regulation of action potential | 1.753089e-3 |
GO:0042420 | dopamine catabolic process | 1.786290e-3 |
GO:0042472 | inner ear morphogenesis | 1.790571e-3 |
GO:0070914 | UV-damage excision repair | 1.793350e-3 |
GO:0010659 | cardiac muscle cell apoptosis | 1.795194e-3 |
GO:0014898 | cardiac muscle hypertrophy in response to stress | 1.832362e-3 |
GO:0009304 | tRNA transcription | 1.832362e-3 |
GO:0090231 | regulation of spindle checkpoint | 1.903447e-3 |
GO:0042471 | ear morphogenesis | 1.915106e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 1.932571e-3 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 1.954165e-3 |
GO:0060318 | definitive erythrocyte differentiation | 1.964903e-3 |
GO:0007417 | central nervous system development | 2.013206e-3 |
GO:0043064 | flagellum organization | 2.030199e-3 |
GO:0051099 | positive regulation of binding | 2.030610e-3 |
GO:0021537 | telencephalon development | 2.031048e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.077894e-3 |
GO:0070593 | dendrite self-avoidance | 2.086030e-3 |
GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 2.087320e-3 |
GO:0035665 | TIRAP-dependent toll-like receptor 4 signaling pathway | 2.087320e-3 |
GO:0032738 | positive regulation of interleukin-15 production | 2.087320e-3 |
GO:0030322 | stabilization of membrane potential | 2.118603e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 2.118603e-3 |
GO:0010940 | positive regulation of necrotic cell death | 2.120785e-3 |
GO:0003417 | growth plate cartilage development | 2.120785e-3 |
GO:0060384 | innervation | 2.157900e-3 |
GO:0010960 | magnesium ion homeostasis | 2.184561e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.208739e-3 |
GO:0016445 | somatic diversification of immunoglobulins | 2.221661e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.232578e-3 |
GO:0010467 | gene expression | 2.243900e-3 |
GO:0090311 | regulation of protein deacetylation | 2.258922e-3 |
GO:0007619 | courtship behavior | 2.262983e-3 |
GO:2000171 | negative regulation of dendrite development | 2.328240e-3 |
GO:0021532 | neural tube patterning | 2.342848e-3 |
GO:0021562 | vestibulocochlear nerve development | 2.375941e-3 |
GO:0060179 | male mating behavior | 2.378128e-3 |
GO:0030223 | neutrophil differentiation | 2.384174e-3 |
GO:0048320 | axial mesoderm formation | 2.398168e-3 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 2.414146e-3 |
GO:0008045 | motor axon guidance | 2.447485e-3 |
GO:0048663 | neuron fate commitment | 2.473026e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.474239e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 2.474239e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 2.474239e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 2.474239e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.474239e-3 |
GO:0000917 | barrier septum formation | 2.474239e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 2.474239e-3 |
GO:0021586 | pons maturation | 2.474239e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.474239e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 2.474239e-3 |
GO:0006644 | phospholipid metabolic process | 2.484383e-3 |
GO:0042730 | fibrinolysis | 2.496599e-3 |
GO:0060083 | smooth muscle contraction involved in micturition | 2.557878e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.656673e-3 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 2.665068e-3 |
GO:0018958 | phenol-containing compound metabolic process | 2.668239e-3 |
GO:0003093 | regulation of glomerular filtration | 2.720096e-3 |
GO:0007549 | dosage compensation | 2.720096e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 2.720096e-3 |
GO:0006289 | nucleotide-excision repair | 2.733152e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 2.739314e-3 |
GO:0002543 | activation of blood coagulation via clotting cascade | 2.797334e-3 |
GO:0060465 | pharynx development | 2.846440e-3 |
GO:0042942 | D-serine transport | 2.846440e-3 |
GO:0060611 | mammary gland fat development | 2.938887e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 2.938887e-3 |
GO:0060438 | trachea development | 2.940115e-3 |
GO:0006382 | adenosine to inosine editing | 2.964947e-3 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 2.964947e-3 |
GO:2000627 | positive regulation of miRNA catabolic process | 2.998438e-3 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 2.998438e-3 |
GO:0050955 | thermoception | 2.998438e-3 |
GO:0000964 | mitochondrial RNA 5'-end processing | 2.998438e-3 |
GO:0043388 | positive regulation of DNA binding | 3.027219e-3 |
GO:0007635 | chemosensory behavior | 3.030284e-3 |
GO:0019226 | transmission of nerve impulse | 3.055741e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 3.084628e-3 |
GO:0045638 | negative regulation of myeloid cell differentiation | 3.087048e-3 |
GO:0032185 | septin cytoskeleton organization | 3.096483e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 3.182913e-3 |
GO:0030851 | granulocyte differentiation | 3.187937e-3 |
GO:0006781 | succinyl-CoA pathway | 3.191384e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 3.191384e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 3.191384e-3 |
GO:0030150 | protein import into mitochondrial matrix | 3.201558e-3 |
GO:0001672 | regulation of chromatin assembly or disassembly | 3.222836e-3 |
GO:0034776 | response to histamine | 3.223429e-3 |
GO:0071422 | succinate transmembrane transport | 3.223429e-3 |
GO:0008216 | spermidine metabolic process | 3.223429e-3 |
GO:0007623 | circadian rhythm | 3.288257e-3 |
GO:0006290 | pyrimidine dimer repair | 3.302071e-3 |
GO:0021636 | trigeminal nerve morphogenesis | 3.313900e-3 |
GO:0003014 | renal system process | 3.419691e-3 |
GO:0016197 | endosome transport | 3.439822e-3 |
GO:0035456 | response to interferon-beta | 3.466797e-3 |
GO:0043300 | regulation of leukocyte degranulation | 3.495674e-3 |
GO:0070340 | detection of bacterial lipopeptide | 3.524895e-3 |
GO:0035928 | rRNA import into mitochondrion | 3.524895e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 3.534309e-3 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 3.541948e-3 |
GO:0032409 | regulation of transporter activity | 3.547457e-3 |
GO:0035873 | lactate transmembrane transport | 3.600832e-3 |
GO:0060301 | positive regulation of cytokine activity | 3.647276e-3 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 3.647276e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 3.708243e-3 |
GO:0016233 | telomere capping | 3.728878e-3 |
GO:0003181 | atrioventricular valve morphogenesis | 3.754651e-3 |
GO:0021602 | cranial nerve morphogenesis | 3.825285e-3 |
GO:0042417 | dopamine metabolic process | 3.826827e-3 |
GO:0046500 | S-adenosylmethionine metabolic process | 3.847344e-3 |
GO:0003416 | endochondral bone growth | 3.848464e-3 |
GO:0042886 | amide transport | 3.848464e-3 |
GO:0008355 | olfactory learning | 3.898688e-3 |
GO:0001507 | acetylcholine catabolic process in synaptic cleft | 3.898688e-3 |
GO:0042093 | T-helper cell differentiation | 3.964202e-3 |
GO:0007270 | neuron-neuron synaptic transmission | 3.966450e-3 |
GO:0007386 | compartment pattern specification | 3.991467e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 4.018357e-3 |
GO:0045920 | negative regulation of exocytosis | 4.049334e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 4.099021e-3 |
GO:0043534 | blood vessel endothelial cell migration | 4.122152e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 4.176855e-3 |
GO:0006208 | pyrimidine base catabolic process | 4.178550e-3 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 4.180459e-3 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 4.285511e-3 |
GO:0021623 | oculomotor nerve formation | 4.300737e-3 |
GO:0051382 | kinetochore assembly | 4.300737e-3 |
GO:0003409 | optic cup structural organization | 4.300737e-3 |
GO:0003404 | optic vesicle morphogenesis | 4.300737e-3 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 4.303131e-3 |
GO:0071276 | cellular response to cadmium ion | 4.363677e-3 |
GO:0060839 | endothelial cell fate commitment | 4.363677e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 4.363677e-3 |
GO:0016045 | detection of bacterium | 4.367888e-3 |
GO:0021697 | cerebellar cortex formation | 4.428426e-3 |
GO:0071899 | negative regulation of estrogen receptor binding | 4.474843e-3 |
GO:0003285 | septum secundum development | 4.502290e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 4.509209e-3 |
GO:0021517 | ventral spinal cord development | 4.510574e-3 |
GO:0032376 | positive regulation of cholesterol transport | 4.511451e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 4.512661e-3 |
GO:0048486 | parasympathetic nervous system development | 4.512661e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 4.523503e-3 |
GO:0015747 | urate transport | 4.589928e-3 |
GO:2000772 | regulation of cellular senescence | 4.630915e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 4.634573e-3 |
GO:0060019 | radial glial cell differentiation | 4.638387e-3 |
GO:0032648 | regulation of interferon-beta production | 4.691191e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 4.694285e-3 |
GO:0010452 | histone H3-K36 methylation | 4.752022e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 5.010445e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 5.010445e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 5.075455e-3 |
GO:0006575 | cellular modified amino acid metabolic process | 5.203936e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 5.311840e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 5.312142e-3 |
GO:0032481 | positive regulation of type I interferon production | 5.386183e-3 |
GO:0022898 | regulation of transmembrane transporter activity | 5.417556e-3 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 5.435637e-3 |
GO:0008306 | associative learning | 5.438412e-3 |
GO:0030221 | basophil differentiation | 5.451227e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 5.486057e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 5.594391e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 5.594391e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 5.594391e-3 |
GO:0003322 | pancreatic A cell development | 5.594391e-3 |
GO:0015820 | leucine transport | 5.634069e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 5.657676e-3 |
GO:0006083 | acetate metabolic process | 5.686389e-3 |
GO:0010587 | miRNA catabolic process | 5.686389e-3 |
GO:0043029 | T cell homeostasis | 5.777682e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 5.791889e-3 |
GO:0007588 | excretion | 5.850237e-3 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 5.981980e-3 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 5.981980e-3 |
GO:0060166 | olfactory pit development | 5.989812e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 5.989812e-3 |
GO:0048665 | neuron fate specification | 6.019664e-3 |
GO:0032764 | negative regulation of mast cell cytokine production | 6.062659e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 6.177055e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 6.179107e-3 |
GO:0090342 | regulation of cell aging | 6.197003e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 6.240430e-3 |
GO:0050819 | negative regulation of coagulation | 6.263183e-3 |
GO:0042416 | dopamine biosynthetic process | 6.327298e-3 |
GO:0016180 | snRNA processing | 6.346593e-3 |
GO:0042312 | regulation of vasodilation | 6.352142e-3 |
GO:0061037 | negative regulation of cartilage development | 6.387312e-3 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 6.387312e-3 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 6.453752e-3 |
GO:0021797 | forebrain anterior/posterior pattern specification | 6.480641e-3 |
GO:0021681 | cerebellar granular layer development | 6.491982e-3 |
GO:0060306 | regulation of membrane repolarization | 6.592028e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 6.593018e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 6.593390e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 6.652903e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 6.652903e-3 |
GO:0060464 | lung lobe formation | 6.703347e-3 |
GO:0071800 | podosome assembly | 6.703347e-3 |
GO:0009235 | cobalamin metabolic process | 6.703347e-3 |
GO:0042537 | benzene-containing compound metabolic process | 6.703753e-3 |
GO:0019264 | glycine biosynthetic process from serine | 6.770894e-3 |
GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 6.770894e-3 |
GO:0046886 | positive regulation of hormone biosynthetic process | 6.788448e-3 |
GO:0014832 | urinary bladder smooth muscle contraction | 6.805319e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 6.894834e-3 |
GO:0010034 | response to acetate | 6.949181e-3 |
GO:0021533 | cell differentiation in hindbrain | 7.044352e-3 |
GO:0006173 | dADP biosynthetic process | 7.051650e-3 |
GO:0015734 | taurine transport | 7.051650e-3 |
GO:0035129 | post-embryonic hindlimb morphogenesis | 7.172700e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7.172700e-3 |
GO:0006746 | FADH2 metabolic process | 7.172700e-3 |
GO:0051101 | regulation of DNA binding | 7.212751e-3 |
GO:0035767 | endothelial cell chemotaxis | 7.213494e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 7.236644e-3 |
GO:0014909 | smooth muscle cell migration | 7.294859e-3 |
GO:0043967 | histone H4 acetylation | 7.341283e-3 |
GO:0035082 | axoneme assembly | 7.352007e-3 |
GO:0033327 | Leydig cell differentiation | 7.356778e-3 |
GO:0032461 | positive regulation of protein oligomerization | 7.371212e-3 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 7.398816e-3 |
GO:0060406 | positive regulation of penile erection | 7.398816e-3 |
GO:0021761 | limbic system development | 7.427905e-3 |
GO:0006809 | nitric oxide biosynthetic process | 7.481538e-3 |
GO:0009744 | response to sucrose stimulus | 7.496842e-3 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 7.516640e-3 |
GO:0006268 | DNA unwinding involved in replication | 7.516640e-3 |
GO:0006487 | protein N-linked glycosylation | 7.563188e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 7.566734e-3 |
GO:0019228 | regulation of action potential in neuron | 7.730497e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 7.763187e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 7.777960e-3 |
GO:0021952 | central nervous system projection neuron axonogenesis | 7.865494e-3 |
GO:0090103 | cochlea morphogenesis | 7.871313e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 7.935849e-3 |
GO:0021587 | cerebellum morphogenesis | 8.037074e-3 |
GO:0035725 | sodium ion transmembrane transport | 8.056702e-3 |
GO:0017004 | cytochrome complex assembly | 8.190345e-3 |
GO:0070172 | positive regulation of tooth mineralization | 8.232241e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 1.281916e-13 |
GO:0044260 | cellular macromolecule metabolic process | 1.718884e-12 |
GO:0030488 | tRNA methylation | 1.463100e-11 |
GO:0010467 | gene expression | 2.460171e-11 |
GO:0016070 | RNA metabolic process | 2.636615e-11 |
GO:0090304 | nucleic acid metabolic process | 6.345604e-11 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.826068e-10 |
GO:0006807 | nitrogen compound metabolic process | 1.388301e-9 |
GO:0032465 | regulation of cytokinesis | 1.405173e-9 |
GO:0032467 | positive regulation of cytokinesis | 4.763529e-9 |
GO:0032774 | RNA biosynthetic process | 5.149999e-9 |
GO:0008033 | tRNA processing | 6.437773e-9 |
GO:0043170 | macromolecule metabolic process | 7.687860e-9 |
GO:0044237 | cellular metabolic process | 9.860189e-9 |
GO:0006351 | transcription, DNA-dependent | 1.036565e-8 |
GO:0006400 | tRNA modification | 1.813981e-8 |
GO:0034614 | cellular response to reactive oxygen species | 3.113785e-8 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 5.147024e-8 |
GO:0051301 | cell division | 6.180686e-8 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6.636600e-8 |
GO:0055090 | acylglycerol homeostasis | 7.527995e-8 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.280123e-7 |
GO:0051890 | regulation of cardioblast differentiation | 1.342906e-7 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.331043e-7 |
GO:0006783 | heme biosynthetic process | 2.647003e-7 |
GO:0035886 | vascular smooth muscle cell differentiation | 3.172631e-7 |
GO:0044238 | primary metabolic process | 3.806056e-7 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5.018926e-7 |
GO:0060575 | intestinal epithelial cell differentiation | 6.206279e-7 |
GO:0051171 | regulation of nitrogen compound metabolic process | 7.663784e-7 |
GO:0018202 | peptidyl-histidine modification | 9.708052e-7 |
GO:0051302 | regulation of cell division | 9.753220e-7 |
GO:0060440 | trachea formation | 1.206336e-6 |
GO:0060439 | trachea morphogenesis | 1.244517e-6 |
GO:0044249 | cellular biosynthetic process | 1.508801e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.758077e-6 |
GO:0006399 | tRNA metabolic process | 1.809596e-6 |
GO:0042168 | heme metabolic process | 1.821578e-6 |
GO:0090084 | negative regulation of inclusion body assembly | 3.670739e-6 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 3.838857e-6 |
GO:0006778 | porphyrin-containing compound metabolic process | 4.163762e-6 |
GO:0035137 | hindlimb morphogenesis | 4.336975e-6 |
GO:0051781 | positive regulation of cell division | 4.605528e-6 |
GO:0008344 | adult locomotory behavior | 5.153067e-6 |
GO:0006355 | regulation of transcription, DNA-dependent | 5.326805e-6 |
GO:0009059 | macromolecule biosynthetic process | 5.486987e-6 |
GO:0001510 | RNA methylation | 5.607103e-6 |
GO:0009058 | biosynthetic process | 5.974163e-6 |
GO:0090086 | negative regulation of protein deubiquitination | 7.718065e-6 |
GO:0031326 | regulation of cellular biosynthetic process | 8.640983e-6 |
GO:0030902 | hindbrain development | 1.164266e-5 |
GO:0051252 | regulation of RNA metabolic process | 1.513465e-5 |
GO:0070301 | cellular response to hydrogen peroxide | 1.538226e-5 |
GO:0007224 | smoothened signaling pathway | 1.633105e-5 |
GO:0034470 | ncRNA processing | 1.637881e-5 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.662611e-5 |
GO:0070588 | calcium ion transmembrane transport | 1.680690e-5 |
GO:0033013 | tetrapyrrole metabolic process | 1.780197e-5 |
GO:0006982 | response to lipid hydroperoxide | 1.787424e-5 |
GO:0060433 | bronchus development | 2.055499e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 2.244741e-5 |
GO:0009451 | RNA modification | 2.246129e-5 |
GO:0002663 | positive regulation of B cell tolerance induction | 2.259339e-5 |
GO:0009889 | regulation of biosynthetic process | 2.267361e-5 |
GO:0001570 | vasculogenesis | 2.461306e-5 |
GO:0061036 | positive regulation of cartilage development | 2.695612e-5 |
GO:0030520 | estrogen receptor signaling pathway | 2.919024e-5 |
GO:0022038 | corpus callosum development | 3.418416e-5 |
GO:0006390 | transcription from mitochondrial promoter | 3.864965e-5 |
GO:0060164 | regulation of timing of neuron differentiation | 3.952966e-5 |
GO:0070327 | thyroid hormone transport | 4.152975e-5 |
GO:0007628 | adult walking behavior | 4.450197e-5 |
GO:0030534 | adult behavior | 4.459789e-5 |
GO:0007420 | brain development | 4.520968e-5 |
GO:0060010 | Sertoli cell fate commitment | 4.538995e-5 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 4.731276e-5 |
GO:0007256 | activation of JNKK activity | 4.838085e-5 |
GO:0006713 | glucocorticoid catabolic process | 4.902833e-5 |
GO:0051891 | positive regulation of cardioblast differentiation | 5.338628e-5 |
GO:0001706 | endoderm formation | 5.429678e-5 |
GO:0031323 | regulation of cellular metabolic process | 6.747645e-5 |
GO:0032862 | activation of Rho GTPase activity | 7.948260e-5 |
GO:0006261 | DNA-dependent DNA replication | 8.008945e-5 |
GO:0046426 | negative regulation of JAK-STAT cascade | 8.149324e-5 |
GO:0048554 | positive regulation of metalloenzyme activity | 8.378870e-5 |
GO:0065005 | protein-lipid complex assembly | 8.819913e-5 |
GO:0000959 | mitochondrial RNA metabolic process | 9.026795e-5 |
GO:0060438 | trachea development | 1.014864e-4 |
GO:0060319 | primitive erythrocyte differentiation | 1.082460e-4 |
GO:0046102 | inosine metabolic process | 1.213989e-4 |
GO:0021517 | ventral spinal cord development | 1.335691e-4 |
GO:0071585 | detoxification of cadmium ion | 1.348030e-4 |
GO:0009987 | cellular process | 1.366704e-4 |
GO:0032856 | activation of Ras GTPase activity | 1.374835e-4 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 1.404359e-4 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 1.423198e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.429498e-4 |
GO:0008152 | metabolic process | 1.474718e-4 |
GO:0018193 | peptidyl-amino acid modification | 1.496351e-4 |
GO:0007398 | ectoderm development | 1.498264e-4 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.621769e-4 |
GO:0002227 | innate immune response in mucosa | 1.680682e-4 |
GO:0042697 | menopause | 1.758960e-4 |
GO:0061113 | pancreas morphogenesis | 1.789054e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.926897e-4 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.929050e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.969321e-4 |
GO:0003349 | epicardium-derived cardiac endothelial cell differentiation | 2.034916e-4 |
GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation | 2.034916e-4 |
GO:0002651 | positive regulation of tolerance induction to self antigen | 2.089260e-4 |
GO:0034379 | very-low-density lipoprotein particle assembly | 2.163094e-4 |
GO:0070328 | triglyceride homeostasis | 2.178152e-4 |
GO:0001709 | cell fate determination | 2.231729e-4 |
GO:0070838 | divalent metal ion transport | 2.430774e-4 |
GO:0035116 | embryonic hindlimb morphogenesis | 2.500523e-4 |
GO:0050807 | regulation of synapse organization | 2.522433e-4 |
GO:0010468 | regulation of gene expression | 2.585031e-4 |
GO:0048511 | rhythmic process | 2.647113e-4 |
GO:0021756 | striatum development | 2.680423e-4 |
GO:0072511 | divalent inorganic cation transport | 2.709822e-4 |
GO:0048645 | organ formation | 2.952502e-4 |
GO:0031914 | negative regulation of synaptic plasticity | 2.972816e-4 |
GO:0010722 | regulation of ferrochelatase activity | 2.972816e-4 |
GO:0060216 | definitive hemopoiesis | 3.020129e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.051537e-4 |
GO:0060375 | regulation of mast cell differentiation | 3.051537e-4 |
GO:0021987 | cerebral cortex development | 3.345623e-4 |
GO:0045686 | negative regulation of glial cell differentiation | 3.445250e-4 |
GO:0032259 | methylation | 3.521189e-4 |
GO:0006396 | RNA processing | 3.712479e-4 |
GO:0090361 | regulation of platelet-derived growth factor production | 3.760155e-4 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 3.779588e-4 |
GO:0032606 | type I interferon production | 3.853909e-4 |
GO:0008054 | cyclin catabolic process | 3.853909e-4 |
GO:0043491 | protein kinase B signaling cascade | 3.879987e-4 |
GO:0060591 | chondroblast differentiation | 3.912589e-4 |
GO:0003136 | negative regulation of heart induction by canonical Wnt receptor signaling pathway | 3.987163e-4 |
GO:0001514 | selenocysteine incorporation | 3.987163e-4 |
GO:0002575 | basophil chemotaxis | 3.987163e-4 |
GO:0021954 | central nervous system neuron development | 4.010503e-4 |
GO:0048333 | mesodermal cell differentiation | 4.064216e-4 |
GO:0034660 | ncRNA metabolic process | 4.086131e-4 |
GO:0072337 | modified amino acid transport | 4.111763e-4 |
GO:0090085 | regulation of protein deubiquitination | 4.156824e-4 |
GO:0046591 | embryonic leg joint morphogenesis | 4.156824e-4 |
GO:0034616 | response to laminar fluid shear stress | 4.261237e-4 |
GO:2000736 | regulation of stem cell differentiation | 4.284405e-4 |
GO:0021562 | vestibulocochlear nerve development | 4.296158e-4 |
GO:0040032 | post-embryonic body morphogenesis | 4.336794e-4 |
GO:0015969 | guanosine tetraphosphate metabolic process | 4.700569e-4 |
GO:0071169 | establishment of protein localization to chromatin | 4.700569e-4 |
GO:0040015 | negative regulation of multicellular organism growth | 4.727609e-4 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 4.838353e-4 |
GO:0055091 | phospholipid homeostasis | 4.838353e-4 |
GO:0001824 | blastocyst development | 4.912011e-4 |
GO:0034599 | cellular response to oxidative stress | 5.096951e-4 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 5.315174e-4 |
GO:0001710 | mesodermal cell fate commitment | 5.345996e-4 |
GO:0001704 | formation of primary germ layer | 5.353445e-4 |
GO:0009067 | aspartate family amino acid biosynthetic process | 5.438304e-4 |
GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 5.486204e-4 |
GO:0000722 | telomere maintenance via recombination | 5.636762e-4 |
GO:0001522 | pseudouridine synthesis | 5.641535e-4 |
GO:0008306 | associative learning | 5.711840e-4 |
GO:0051963 | regulation of synapse assembly | 6.024640e-4 |
GO:0080090 | regulation of primary metabolic process | 6.039898e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 6.106116e-4 |
GO:0035136 | forelimb morphogenesis | 6.248966e-4 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 6.274408e-4 |
GO:0007498 | mesoderm development | 6.279725e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 6.329649e-4 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 6.532209e-4 |
GO:0033151 | V(D)J recombination | 6.567139e-4 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.603561e-4 |
GO:0021953 | central nervous system neuron differentiation | 6.691314e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 6.735494e-4 |
GO:0006816 | calcium ion transport | 7.004035e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 7.042436e-4 |
GO:0072079 | nephron tubule formation | 7.055820e-4 |
GO:0007067 | mitosis | 7.072000e-4 |
GO:0046103 | inosine biosynthetic process | 7.177803e-4 |
GO:0060971 | embryonic heart tube left/right pattern formation | 7.177803e-4 |
GO:0008208 | C21-steroid hormone catabolic process | 7.177803e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 7.177803e-4 |
GO:0006154 | adenosine catabolic process | 7.177803e-4 |
GO:0048665 | neuron fate specification | 7.221185e-4 |
GO:0007626 | locomotory behavior | 7.376649e-4 |
GO:0031398 | positive regulation of protein ubiquitination | 8.032461e-4 |
GO:0021781 | glial cell fate commitment | 8.247153e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 8.256835e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.401964e-4 |
GO:0034220 | ion transmembrane transport | 8.558194e-4 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 8.600429e-4 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 8.600429e-4 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 8.693243e-4 |
GO:0019230 | proprioception | 8.693243e-4 |
GO:0031508 | centromeric heterochromatin formation | 8.893847e-4 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 9.021193e-4 |
GO:0060073 | micturition | 9.115390e-4 |
GO:0033136 | serine phosphorylation of STAT3 protein | 9.186302e-4 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 9.186302e-4 |
GO:0006688 | glycosphingolipid biosynthetic process | 9.485545e-4 |
GO:0046543 | development of secondary female sexual characteristics | 9.734743e-4 |
GO:0090281 | negative regulation of calcium ion import | 9.945757e-4 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 9.945757e-4 |
GO:0071584 | negative regulation of zinc ion import | 9.945757e-4 |
GO:0045165 | cell fate commitment | 1.014587e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 1.038320e-3 |
GO:0072141 | renal interstitial cell development | 1.050057e-3 |
GO:0021549 | cerebellum development | 1.061184e-3 |
GO:0048266 | behavioral response to pain | 1.121695e-3 |
GO:0000087 | M phase of mitotic cell cycle | 1.148550e-3 |
GO:0021571 | rhombomere 5 development | 1.155207e-3 |
GO:0070574 | cadmium ion transmembrane transport | 1.155207e-3 |
GO:0097084 | vascular smooth muscle cell development | 1.191846e-3 |
GO:0010452 | histone H3-K36 methylation | 1.191846e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1.191846e-3 |
GO:0032801 | receptor catabolic process | 1.201777e-3 |
GO:0003310 | pancreatic A cell differentiation | 1.202824e-3 |
GO:0031576 | G2/M transition checkpoint | 1.235150e-3 |
GO:0071241 | cellular response to inorganic substance | 1.243345e-3 |
GO:0043117 | positive regulation of vascular permeability | 1.266221e-3 |
GO:0018205 | peptidyl-lysine modification | 1.267807e-3 |
GO:0016570 | histone modification | 1.283617e-3 |
GO:0072078 | nephron tubule morphogenesis | 1.298382e-3 |
GO:0072190 | ureter urothelium development | 1.321715e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.328313e-3 |
GO:0043414 | macromolecule methylation | 1.343799e-3 |
GO:0051188 | cofactor biosynthetic process | 1.345377e-3 |
GO:0007403 | glial cell fate determination | 1.381757e-3 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 1.404688e-3 |
GO:0046604 | positive regulation of mitotic centrosome separation | 1.404688e-3 |
GO:2000682 | positive regulation of rubidium ion transport | 1.404688e-3 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 1.404688e-3 |
GO:0035826 | rubidium ion transport | 1.404688e-3 |
GO:0035621 | ER to Golgi ceramide transport | 1.416464e-3 |
GO:0032232 | negative regulation of actin filament bundle assembly | 1.436268e-3 |
GO:0060038 | cardiac muscle cell proliferation | 1.441815e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.447443e-3 |
GO:0008211 | glucocorticoid metabolic process | 1.475704e-3 |
GO:0048505 | regulation of timing of cell differentiation | 1.479025e-3 |
GO:0034501 | protein localization to kinetochore | 1.489859e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.489859e-3 |
GO:0009086 | methionine biosynthetic process | 1.499376e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1.499689e-3 |
GO:0061154 | endothelial tube morphogenesis | 1.499689e-3 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 1.499689e-3 |
GO:0044267 | cellular protein metabolic process | 1.505756e-3 |
GO:0022037 | metencephalon development | 1.523503e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 1.533474e-3 |
GO:0060419 | heart growth | 1.540494e-3 |
GO:0048389 | intermediate mesoderm development | 1.616829e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 1.616829e-3 |
GO:0061333 | renal tubule morphogenesis | 1.619497e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 1.643271e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.648466e-3 |
GO:0007612 | learning | 1.657409e-3 |
GO:0048745 | smooth muscle tissue development | 1.682004e-3 |
GO:0006284 | base-excision repair | 1.682599e-3 |
GO:0046373 | L-arabinose metabolic process | 1.705136e-3 |
GO:0046130 | purine ribonucleoside catabolic process | 1.709667e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 1.728549e-3 |
GO:0007610 | behavior | 1.764395e-3 |
GO:0016569 | covalent chromatin modification | 1.809547e-3 |
GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis | 1.817795e-3 |
GO:0007517 | muscle organ development | 1.840538e-3 |
GO:0048541 | Peyer's patch development | 1.841180e-3 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 1.874152e-3 |
GO:0034635 | glutathione transport | 1.874152e-3 |
GO:0046952 | ketone body catabolic process | 1.874152e-3 |
GO:0045351 | type I interferon biosynthetic process | 1.890685e-3 |
GO:0045738 | negative regulation of DNA repair | 1.902542e-3 |
GO:0042501 | serine phosphorylation of STAT protein | 1.902542e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 1.907052e-3 |
GO:0070836 | caveola assembly | 1.907052e-3 |
GO:0021758 | putamen development | 1.907052e-3 |
GO:0021757 | caudate nucleus development | 1.907052e-3 |
GO:0006481 | C-terminal protein methylation | 1.948420e-3 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.952500e-3 |
GO:0050773 | regulation of dendrite development | 1.959943e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.967929e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 1.991585e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 2.044003e-3 |
GO:0000278 | mitotic cell cycle | 2.048413e-3 |
GO:0046777 | protein autophosphorylation | 2.113851e-3 |
GO:0021544 | subpallium development | 2.191227e-3 |
GO:0001574 | ganglioside biosynthetic process | 2.194996e-3 |
GO:0010464 | regulation of mesenchymal cell proliferation | 2.200317e-3 |
GO:0021631 | optic nerve morphogenesis | 2.271213e-3 |
GO:0007369 | gastrulation | 2.286362e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 2.308048e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 2.339144e-3 |
GO:0060434 | bronchus morphogenesis | 2.339144e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.339144e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 2.339144e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 2.339144e-3 |
GO:0006730 | one-carbon metabolic process | 2.351050e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 2.363448e-3 |
GO:0060416 | response to growth hormone stimulus | 2.382842e-3 |
GO:0010574 | regulation of vascular endothelial growth factor production | 2.390922e-3 |
GO:0035887 | aortic smooth muscle cell differentiation | 2.393970e-3 |
GO:0021557 | oculomotor nerve development | 2.408167e-3 |
GO:0051965 | positive regulation of synapse assembly | 2.435907e-3 |
GO:0021603 | cranial nerve formation | 2.505486e-3 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.505769e-3 |
GO:0048663 | neuron fate commitment | 2.509847e-3 |
GO:0001708 | cell fate specification | 2.566214e-3 |
GO:0060632 | regulation of microtubule-based movement | 2.581698e-3 |
GO:0051954 | positive regulation of amine transport | 2.605152e-3 |
GO:0006555 | methionine metabolic process | 2.618181e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.659393e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.659393e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 2.669284e-3 |
GO:0048793 | pronephros development | 2.722069e-3 |
GO:0060318 | definitive erythrocyte differentiation | 2.736834e-3 |
GO:0045333 | cellular respiration | 2.825572e-3 |
GO:0019941 | modification-dependent protein catabolic process | 2.833141e-3 |
GO:0031427 | response to methotrexate | 2.837694e-3 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 2.838534e-3 |
GO:0061326 | renal tubule development | 2.846056e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.864416e-3 |
GO:0001832 | blastocyst growth | 2.892922e-3 |
GO:0009190 | cyclic nucleotide biosynthetic process | 2.922767e-3 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.961429e-3 |
GO:0030431 | sleep | 3.046212e-3 |
GO:0007585 | respiratory gaseous exchange | 3.064227e-3 |
GO:0035964 | COPI-coated vesicle budding | 3.103309e-3 |
GO:0002645 | positive regulation of tolerance induction | 3.126211e-3 |
GO:0001833 | inner cell mass cell proliferation | 3.185062e-3 |
GO:0032836 | glomerular basement membrane development | 3.208236e-3 |
GO:2000772 | regulation of cellular senescence | 3.218354e-3 |
GO:0072080 | nephron tubule development | 3.237163e-3 |
GO:0035249 | synaptic transmission, glutamatergic | 3.247389e-3 |
GO:0015669 | gas transport | 3.316069e-3 |
GO:0043412 | macromolecule modification | 3.322983e-3 |
GO:0045768 | positive regulation of anti-apoptosis | 3.323808e-3 |
GO:0060192 | negative regulation of lipase activity | 3.337052e-3 |
GO:0072234 | metanephric nephron tubule development | 3.356549e-3 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 3.371173e-3 |
GO:0090185 | negative regulation of kidney development | 3.388742e-3 |
GO:0070172 | positive regulation of tooth mineralization | 3.388742e-3 |
GO:0072184 | renal vesicle progenitor cell differentiation | 3.501550e-3 |
GO:0072208 | metanephric smooth muscle tissue development | 3.501550e-3 |
GO:0072259 | metanephric interstitial cell development | 3.501550e-3 |
GO:0072169 | specification of posterior mesonephric tubule identity | 3.501550e-3 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 3.501550e-3 |
GO:0072168 | specification of anterior mesonephric tubule identity | 3.501550e-3 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 3.501550e-3 |
GO:0048313 | Golgi inheritance | 3.501550e-3 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 3.501550e-3 |
GO:0048265 | response to pain | 3.526673e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 3.575621e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 3.629544e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 3.629544e-3 |
GO:0046929 | negative regulation of neurotransmitter secretion | 3.633481e-3 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 3.633481e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.717518e-3 |
GO:0035264 | multicellular organism growth | 3.758142e-3 |
GO:0061061 | muscle structure development | 3.758775e-3 |
GO:0090381 | regulation of heart induction | 3.795254e-3 |
GO:0021750 | vestibular nucleus development | 3.795254e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 3.795254e-3 |
GO:0021679 | cerebellar molecular layer development | 3.795254e-3 |
GO:0021590 | cerebellum maturation | 3.795254e-3 |
GO:0003093 | regulation of glomerular filtration | 3.799178e-3 |
GO:0035987 | endodermal cell differentiation | 3.802466e-3 |
GO:0021513 | spinal cord dorsal/ventral patterning | 3.802466e-3 |
GO:0021510 | spinal cord development | 3.840690e-3 |
GO:0042088 | T-helper 1 type immune response | 3.853835e-3 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 3.867917e-3 |
GO:0060492 | lung induction | 3.872543e-3 |
GO:0040023 | establishment of nucleus localization | 3.896236e-3 |
GO:0045601 | regulation of endothelial cell differentiation | 3.959273e-3 |
GO:0060711 | labyrinthine layer development | 3.966689e-3 |
GO:0072170 | metanephric tubule development | 3.973695e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 3.974828e-3 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 3.974828e-3 |
GO:0070079 | histone H4-R3 demethylation | 3.974828e-3 |
GO:0070078 | histone H3-R2 demethylation | 3.974828e-3 |
GO:0060217 | hemangioblast cell differentiation | 3.974828e-3 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 3.974828e-3 |
GO:0043148 | mitotic spindle stabilization | 3.974828e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 3.974828e-3 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 3.974828e-3 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 3.974828e-3 |
GO:0035881 | amacrine cell differentiation | 4.066492e-3 |
GO:0060420 | regulation of heart growth | 4.094893e-3 |
GO:0043543 | protein acylation | 4.100073e-3 |
GO:0021578 | hindbrain maturation | 4.105230e-3 |
GO:0000212 | meiotic spindle organization | 4.105230e-3 |
GO:0070995 | NADPH oxidation | 4.149672e-3 |
GO:0021819 | layer formation in cerebral cortex | 4.149672e-3 |
GO:0048671 | negative regulation of collateral sprouting | 4.149672e-3 |
GO:0033554 | cellular response to stress | 4.153894e-3 |
GO:0060480 | lung goblet cell differentiation | 4.182440e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 4.197607e-3 |
GO:0045645 | positive regulation of eosinophil differentiation | 4.197607e-3 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 4.197607e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 4.197607e-3 |
GO:0048291 | isotype switching to IgG isotypes | 4.197607e-3 |
GO:0021572 | rhombomere 6 development | 4.197607e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 4.197607e-3 |
GO:0002368 | B cell cytokine production | 4.197607e-3 |
GO:0006741 | NADP biosynthetic process | 4.197607e-3 |
GO:0051349 | positive regulation of lyase activity | 4.213988e-3 |
GO:0030326 | embryonic limb morphogenesis | 4.214456e-3 |
GO:0051647 | nucleus localization | 4.233371e-3 |
GO:0008542 | visual learning | 4.261377e-3 |
GO:0055114 | oxidation-reduction process | 4.289862e-3 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 4.305089e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 4.335122e-3 |
GO:0051138 | positive regulation of NK T cell differentiation | 4.383253e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 4.383253e-3 |
GO:0001764 | neuron migration | 4.434219e-3 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 4.450113e-3 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 4.557487e-3 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 4.558391e-3 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 4.558391e-3 |
GO:0072197 | ureter morphogenesis | 4.558391e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 4.558391e-3 |
GO:0051322 | anaphase | 4.579770e-3 |
GO:0045722 | positive regulation of gluconeogenesis | 4.579770e-3 |
GO:0042542 | response to hydrogen peroxide | 4.640578e-3 |
GO:2000015 | regulation of determination of dorsal identity | 4.641839e-3 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 4.641839e-3 |
GO:0051238 | sequestering of metal ion | 4.641839e-3 |
GO:0051899 | membrane depolarization | 4.688090e-3 |
GO:0033091 | positive regulation of immature T cell proliferation | 4.714009e-3 |
GO:0051028 | mRNA transport | 4.727814e-3 |
GO:0040034 | regulation of development, heterochronic | 4.783293e-3 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 4.814643e-3 |
GO:0019222 | regulation of metabolic process | 4.821968e-3 |
GO:0000302 | response to reactive oxygen species | 4.854959e-3 |
GO:0033083 | regulation of immature T cell proliferation | 4.856274e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 4.909682e-3 |
GO:0072148 | epithelial cell fate commitment | 4.909682e-3 |
GO:0007052 | mitotic spindle organization | 4.909682e-3 |
GO:0009060 | aerobic respiration | 4.965126e-3 |
GO:0007519 | skeletal muscle tissue development | 5.007841e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 5.080486e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 5.131764e-3 |
GO:0007379 | segment specification | 5.131764e-3 |
GO:0060083 | smooth muscle contraction involved in micturition | 5.190190e-3 |
GO:0051016 | barbed-end actin filament capping | 5.213340e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 5.246491e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 5.269736e-3 |
GO:0002639 | positive regulation of immunoglobulin production | 5.301183e-3 |
GO:0055069 | zinc ion homeostasis | 5.340216e-3 |
GO:0046686 | response to cadmium ion | 5.343569e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 5.373592e-3 |
GO:0060215 | primitive hemopoiesis | 5.373592e-3 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 5.384151e-3 |
GO:0050803 | regulation of synapse structure and activity | 5.433836e-3 |
GO:0051726 | regulation of cell cycle | 5.462034e-3 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.467604e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 5.574959e-3 |
GO:0043647 | inositol phosphate metabolic process | 5.604460e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 5.604627e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 5.604627e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.609394e-3 |
GO:0006599 | phosphagen metabolic process | 5.610377e-3 |
GO:0008631 | induction of apoptosis by oxidative stress | 5.642484e-3 |
GO:0060484 | lung-associated mesenchyme development | 5.754187e-3 |
GO:0021542 | dentate gyrus development | 5.770853e-3 |
GO:0009247 | glycolipid biosynthetic process | 5.770853e-3 |
GO:0060998 | regulation of dendritic spine development | 5.805931e-3 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 5.837073e-3 |
GO:0006312 | mitotic recombination | 5.837073e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.911959e-3 |
GO:0042268 | regulation of cytolysis | 5.926822e-3 |
GO:0060977 | coronary vasculature morphogenesis | 5.945109e-3 |
GO:0051924 | regulation of calcium ion transport | 5.947969e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 6.010748e-3 |
GO:0071299 | cellular response to vitamin A | 6.019868e-3 |
GO:0045908 | negative regulation of vasodilation | 6.086689e-3 |
GO:0072172 | mesonephric tubule formation | 6.132064e-3 |
GO:0001892 | embryonic placenta development | 6.199841e-3 |
GO:0051597 | response to methylmercury | 6.224972e-3 |
GO:0034101 | erythrocyte homeostasis | 6.274163e-3 |
GO:0033344 | cholesterol efflux | 6.339038e-3 |
GO:0071300 | cellular response to retinoic acid | 6.341522e-3 |
GO:0048285 | organelle fission | 6.427136e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 6.441527e-3 |
GO:0045759 | negative regulation of action potential | 6.441527e-3 |
GO:0006438 | valyl-tRNA aminoacylation | 6.441527e-3 |
GO:0072207 | metanephric epithelium development | 6.449082e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 6.511522e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 6.511522e-3 |
GO:0018130 | heterocycle biosynthetic process | 6.579571e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 6.639011e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 6.690858e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 6.690858e-3 |
GO:0035988 | chondrocyte proliferation | 6.690858e-3 |
GO:2001038 | regulation of cellular response to drug | 6.690858e-3 |
GO:0031052 | chromosome breakage | 6.690858e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 6.690858e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 6.690858e-3 |
GO:0035166 | post-embryonic hemopoiesis | 6.690858e-3 |
GO:0046148 | pigment biosynthetic process | 6.702069e-3 |
GO:0021535 | cell migration in hindbrain | 6.713113e-3 |